Reply To: Traders Market Weekly: Balancing Expectations, Earnings and Money Flow

#62093
MoneyNeverSleeps
Participant

Theseus Pharmaceuticals (THRX) to Discontinue Enrollment in Phase 1/2 Study and Terminate Development of THE-630 in Patients with GIST…

THRX down 73.7%